CXCR2 and prostate carcinoma: CXCR2 expression has been implicated in prostate cancer lineage plasticity and neuroendocrine transformation in the setting of resistance to potent androgen receptor inhibition and is normally expressed on tissue resident neuroendocrine cells [6].